A case with essential tremor refractory to medication successfully treated with deep brain stimulation.
Essential tremor, which is a progressive, age-associated disease, is one of the most common neurological disorders, af fecting up to 5% of indiv iduals aged over 65 years.  As clinical diagnosis of ET is based solely on clinical findings and neurological history, misdiagnosis of ET is common (i.e., Parkinson's disease). [2,3] The management of patients should be determined according to the severity of tremor, the parts of the body involved, physical disability, social disability and handicap. Physical therapy treatment for ET primarily focuses on resistance training and compensatory strategies. Typically, this is applied to the upper extremity to improve strength and coordination, and to reduce tremor severity. In addition to muscle strength, behavioral relaxation therapy has been shown to decrease the tremor severity. 
According to the American Academy of Neurology 2011 practices, beta-blockers, most commonly propranolol, and the anticonvulsant primidone, are the first-line medications for ET (Level A).  The following drugs have recommendations for treating ET: gabapentin, topiramate (Level B, probably effective); botulinum toxin, DBS, and thalamotomy (Level C, possibly effective); gamma knife surgery, pregabalin, zonisamide, and clozapine (Level U, insufficient evidence). In medically refractory patients, limb, head, and voice tremor may respond to botulinum toxin injections into the affected muscles.  Surgical treatment such as thalamotomy or thalamic DBS for ET is reserved for selected patients with severe tremor who are unable to adequately respond to medical and physical therapy. 
In conclusion, while medical therapy, physical therapy and behavioral techniques may be useful in patients with mild to moderate tremor. Vim-DBS for ET can be performed successfully in cases refractory to these therapies or with severe tremor. Neuromodulation applications have revolutionized the approach of physicians interested in movement disorders and rehabilitation, entailing a multidisciplinary approach.
Declaration of conflicting interests
Dr. Yilmaz have disclosures with Boston Scientific and Medtronic in terms of proctorship.
The authors received no financial support for the research and/or authorship of this article.
[1.] Louis ED, Ferreira JJ. How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor. Mov Disord 2010;25:534-41.
[2.] Louis ED. Clinical practice. Essential tremor. N Engl J Med 2001;34 5:887-91.
[3.] Abdo WF, van de Warrenburg BP, Burn DJ, Quinn NP, Bloem BR. The clinical approach to movement disorders. Nat Rev Neurol 2010;6:29-37.
[4.] Hedera P, Cibulcik F, Davis TL. Pharmacotherapy of essential tremor. J Cent Nerv Syst Dis 2013;5:43-55.
[5.] Zesiewicz TA, Elble RJ, Louis ED, Gronseth GS, Ondo WG, Dewey RB Jr, et al. Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology. Neurology 2011;77:1752-5.
Atilla Yilmaz (1), Mustafa Turgut Yildizgoren (2), Emine Esra Okuyucu (3)
(1) Department of Neurosurgery, Mustafa Kemal University Medical School, Hatay, Turkey
(2) Department of Physical Medicine and Rehabilitation, Mustafa Kemal University Medical School, Hatay, Turkey
(3) Department of Neurology, Mustafa Kemal University Medical School, Hatay, Turkey
Received: November 2017 Accepted: March 2018
|Printer friendly Cite/link Email Feedback|
|Author:||Yilmaz, Atilla; Yildizgoren, Mustafa Turgut; Okuyucu, Emine Esra|
|Publication:||Turkish Journal of Physical Medicine and Rehabilitation|
|Article Type:||Case study|
|Date:||Jun 1, 2018|
|Previous Article:||Ulnar neuropathy due to heterotopic ossification: A rare complication after stroke.|
|Next Article:||Lymphedema diagnosis, treatment, and follow-up from the view point of physical medicine and rehabilitation specialists.|